Renoprotective effect of small doses of losartan and enalapril in patients with primary glomerulonephritis: Short-term observation

American Journal of Nephrology

Volumn 22, Issue 4, 2002, Pages 356-362

  Tylicki, Leszek ^a   Rutkowski, Przemyslaw ^a   Renke, Marcin ^a   Rutkowski, Boleslaw ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Angiotensin II receptor blockers; Angiotensin converting enzyme inhibitors; Glomerulonephrits; Kidney; Proteinuria

Indexed keywords

CREATININE; ENALAPRIL; LOSARTAN;

ADULT; AGED; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; GLOMERULUS FILTRATION; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLISM; MONOTHERAPY; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; ANALYSIS OF VARIANCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CREATININE; DRUG THERAPY, COMBINATION; ENALAPRIL; FEMALE; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS; HUMANS; HYPERTENSION; LOSARTAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0036048207     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000065227     Document Type: Article

References (24)

1. Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
2. Renal scarring: The role of angiotensin II
3. ACE inhibitors and AT1 receptor antagonists - Beyond the haemodynamic effect
4. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
5. Effect of angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency: The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group
6. Impact of angiotensin II on the kidney: Does an angiotensin II receptor blocker make sense?
7. Short-term effects of angiotensin II receptor blockade in patients with primary glomerulonephritis - Pilot study
8. Targeting TGF-β overexpression in renal disease: Maximizing the antifibrotic action of angiotensin II blockade
9. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
10. Losartan reduces albuminuria in patients with essential hypertension: An enalapril controlled 3 months study
11. Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy
12. Angiotensin II antagonists in the treatment of hypertension: More similarities than differences
13. The anti-proteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indometacin
14. Renoprotective effects of angio-tensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
15. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
16. Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy
17. Antiproteinuric effects of losartan in patients with chronic renal diseases
18. Combination ACE inhibitor and angiotesin II receptor antagonist therapy in diabetic nephropathy
19. Safety of the combination of valsartan and benazepril in patients with chronic renal diseases
20. Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury with 5/6 renal mass ablation
21. Cardiovascular and renal protective effects of losartan in spontaneously hypertensive rats with diabetes mellitus
22. The acute renal effects of angiotensin II receptor blockers
23. Response of isolated renal arterioles to acetylocholine, dopamine and bradykinin
24. Interaction of nonpeptide angiotensin II receptor antagonists with the urate transporter in rat renal brush-border membranes